LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Normalized Growth Rate Inhibition Value | Standard Error of the Mean for Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|
BT-20 | JW-7-24-1 | 0.37 | uM | LJP6 | 0.8549 | 0.0404 | 0.8216 | 0.0464 |
BT-20 | JW-7-24-1 | 1.11 | uM | LJP6 | 0.8043 | 0.0836 | 0.7550 | 0.1046 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 0.7000 | 0.1075 | 0.6104 | 0.1427 |
BT-20 | JW-7-24-1 | 10 | uM | LJP6 | 0.3034 | 0.0568 | -0.0316 | 0.0957 |
BT-20 | Dasatinib | 0.04 | uM | LJP5 | 0.8598 | 0.0354 | 0.8309 | 0.0419 |
BT-20 | Dasatinib | 0.04 | uM | LJP6 | 0.5634 | 0.0919 | 0.4134 | 0.1224 |
BT-20 | Dasatinib | 0.12 | uM | LJP5 | 0.6087 | 0.0091 | 0.4958 | 0.0232 |
BT-20 | Dasatinib | 0.12 | uM | LJP6 | 0.4496 | 0.0825 | 0.2317 | 0.1180 |
BT-20 | Dasatinib | 0.37 | uM | LJP5 | 0.3718 | 0.0170 | 0.1228 | 0.0268 |
BT-20 | Dasatinib | 0.37 | uM | LJP6 | 0.3553 | 0.0482 | 0.0701 | 0.0635 |
BT-20 | Dasatinib | 1.11 | uM | LJP5 | 0.3367 | 0.0269 | 0.0584 | 0.0489 |
BT-20 | Dasatinib | 1.11 | uM | LJP6 | 0.2990 | 0.0209 | -0.0334 | 0.0218 |
BT-20 | Dasatinib | 3.33 | uM | LJP5 | 0.2912 | 0.0267 | -0.0278 | 0.0482 |
BT-20 | Dasatinib | 3.33 | uM | LJP6 | 0.2453 | 0.0156 | -0.1421 | 0.0414 |
BT-20 | Dasatinib | 10 | uM | LJP5 | 0.2618 | 0.0165 | -0.0862 | 0.0416 |
BT-20 | Dasatinib | 10 | uM | LJP6 | 0.2008 | 0.0080 | -0.2400 | 0.0360 |
BT-20 | Tozasertib | 0.04 | uM | LJP5 | 0.5355 | 0.0342 | 0.3849 | 0.0668 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 0.3392 | 0.0186 | 0.0628 | 0.0600 |
BT-20 | Tozasertib | 0.37 | uM | LJP5 | 0.2944 | 0.0141 | -0.0205 | 0.0543 |
BT-20 | Tozasertib | 1.11 | uM | LJP5 | 0.2891 | 0.0201 | -0.0318 | 0.0663 |
BT-20 | Tozasertib | 3.33 | uM | LJP5 | 0.2871 | 0.0179 | -0.0355 | 0.0617 |
BT-20 | Tozasertib | 10 | uM | LJP5 | 0.2962 | 0.0205 | -0.0179 | 0.0659 |
BT-20 | Imatinib | 0.04 | uM | LJP6 | 1.0056 | 0.0147 | 1.0048 | 0.0188 |
BT-20 | Imatinib | 0.12 | uM | LJP6 | 1.0162 | 0.0352 | 1.0157 | 0.0434 |
BT-20 | Imatinib | 0.37 | uM | LJP6 | 0.9933 | 0.0135 | 0.9905 | 0.0172 |